Benzinga | May 6, 2021 05:23PM EDT

Anika Therapeutics Q1 EPS $0.06 Beats $(0.12) Estimate, Sales $34.30M Beat $32.20M Estimate

Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.12) by 150 percent. This is a 86.67 percent decrease over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $34.30 million which beat the analyst consensus estimate of $32.20 million by 6.52 percent. This is a 3.10 percent decrease over sales of $35.40 million the same period last year.